
Peter Poon-Hang Lee MD
Hematologic Oncology
Billy Wilder Endowed Professor and Chair, Dept. of Immuno-Oncology, City of Hope Comprehensive Cancer Center
Join to View Full Profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-359-8111
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Peter P. Lee is a hematologist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of California San Diego School of Medicine and has been in practice 28 years. He specializes in hematologic oncology and is experienced in hematologic oncology. Dr. Lee primarily conducts translational research in cancer immunology and immunotherapy. He is Chair of the Department of Immuno-Oncology at the Beckman Research Institute.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1995 - 1999
- University of California (San Francisco) School of MedicineFellowship, Allergy and Immunology, 1992 - 1994
- Scripps Clinic/Scripps Green HospitalResidency, Internal Medicine, 1989 - 1992
- University of California San Diego School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 1990 - 2026
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2006
Publications & Presentations
PubMed
- Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations.Georgio Hawi, Peter S Kim, Peter P Lee
Journal of Theoretical Biology. 2025-10-07 - Lymphocytes and monocytes undergo swift suppression of IL-10R, IL-6R, and IL-2Rβγ signaling under high concentrations of different cytokines.Maxim Kuznetsov, Joao Rodrigues Lima Junior, Russell C Rockne, Sergio Branciamore, Andrei S Rodin
Biorxiv. 2025-05-08 - Ligand Discrimination in Immune Cells: Signal Processing Insights into Immune Dysfunction in ER+ Breast Cancer.Adina Matache, Joao Rodrigues Lima Jr, Maxim Kuznetsov, Konstancja Urbaniak, Sergio Branciamore
Biorxiv. 2025-02-17
Press Mentions
- Can Ivermectin Cure Cancer? Here’s What the Science SaysJuly 7th, 2025
- Here's Why There's so Much Talk About Ivermectin for CancerJune 30th, 2025
- Ivermectin Is Being Touted as a Cure for COVID and Cancer. Here’s What Science SaysApril 2nd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: